{"id":"https://openalex.org/W4247370221","doi":"https://doi.org/10.1021/jm980068d","title":"Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 1. Michael Acceptor Structure\u2212Activity Studies","display_name":"Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 1. Michael Acceptor Structure\u2212Activity Studies","publication_year":1998,"publication_date":"1998-06-30","ids":{"openalex":"https://openalex.org/W4247370221","doi":"https://doi.org/10.1021/jm980068d"},"language":"en","primary_location":{"id":"doi:10.1021/jm980068d","doi":"https://doi.org/10.1021/jm980068d","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm980068d","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054082820","display_name":"Peter S. Dragovich","orcid":"https://orcid.org/0000-0001-7372-2862","observed_orcids":["https://orcid.org/0000-0001-7372-2862"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter S. Dragovich","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108478289","display_name":"Stephen E. Webber","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen E. Webber","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073199142","display_name":"Robert E. Babine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert E. Babine","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109111843","display_name":"Shella A. Fuhrman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shella A. Fuhrman","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004742575","display_name":"Amy K. Patick","orcid":"https://orcid.org/0009-0001-1305-0408","observed_orcids":["https://orcid.org/0009-0001-1305-0408"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy K. Patick","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"David A. Matthews","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A. Matthews","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061422874","display_name":"Caroline A. Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline A. Lee","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058385152","display_name":"Siegfried Reich","orcid":"https://orcid.org/0000-0002-6840-2618","observed_orcids":["https://orcid.org/0000-0002-6840-2618"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Siegfried H. Reich","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044131903","display_name":"Thomas J. Prins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas J. Prins","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030396403","display_name":"Joseph T. Marakovits","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph T. Marakovits","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058327821","display_name":"Ethel S. Littlefield","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ethel S. Littlefield","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101506166","display_name":"Ru Zhou","orcid":"https://orcid.org/0009-0007-3653-1902","observed_orcids":["https://orcid.org/0009-0007-3653-1902"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ru Zhou","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061819719","display_name":"Jayashree G. Tikhe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jayashree Tikhe","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057718804","display_name":"Clifford E. Ford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clifford E. Ford","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael B. Wallace","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael B. Wallace","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064620794","display_name":"James W. Meador","orcid":"https://orcid.org/0000-0002-5783-4327","observed_orcids":["https://orcid.org/0000-0002-5783-4327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James W. Meador","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057588461","display_name":"Rose Ann Ferre","orcid":"https://orcid.org/0000-0001-7462-1879","observed_orcids":["https://orcid.org/0000-0001-7462-1879"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rose Ann Ferre","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113667495","display_name":"Edward L. Brown","orcid":"https://orcid.org/0000-0001-7590-0394","observed_orcids":["https://orcid.org/0000-0001-7590-0394"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward L. Brown","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050969899","display_name":"Susan L. Binford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan L. Binford","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043570004","display_name":"James E. V. Harr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James E. V. Harr","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011230724","display_name":"Dorothy M. DeLisle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dorothy M. DeLisle","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034293304","display_name":"Stephen T. Worland","orcid":"https://orcid.org/0000-0001-8924-253X","observed_orcids":["https://orcid.org/0000-0001-8924-253X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen T. Worland","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":8.5959,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.98359701,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"41","issue":"15","first_page":"2806","last_page":"2818"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.30000001192092896,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.30000001192092896,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.25290000438690186,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11162","display_name":"Enzyme Structure and Function","score":0.07680000364780426,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.7009999752044678},{"id":"https://openalex.org/keywords/michael-acceptors","display_name":"Michael acceptors","score":0.7440000176429749},{"id":"https://openalex.org/keywords/irreversible-inhibition","display_name":"irreversible inhibition","score":0.5519999861717224},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8679999709129333},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.8190000057220459},{"id":"https://openalex.org/keywords/crystal-structure","display_name":"crystal structure","score":0.8220000267028809},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.7480000257492065}],"concepts":[{"id":"https://openalex.org/C2779278377","wikidata":"https://www.wikidata.org/wiki/Q1351647","display_name":"Rhinovirus","level":3,"score":0.8834177255630493},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.802423894405365},{"id":"https://openalex.org/C2777366897","wikidata":"https://www.wikidata.org/wiki/Q847482","display_name":"HeLa","level":3,"score":0.6746412515640259},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5296088457107544},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.5195903778076172},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.5187323689460754},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.4798007309436798},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.4682014584541321},{"id":"https://openalex.org/C2779892579","wikidata":"https://www.wikidata.org/wiki/Q912138","display_name":"Acceptor","level":2,"score":0.445382297039032},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4392312169075012},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3641563951969147},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3440249562263489},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.25363004207611084},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.22358974814414978},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21096214652061462},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0758216381072998},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.05481529235839844},{"id":"https://openalex.org/C26873012","wikidata":"https://www.wikidata.org/wiki/Q214781","display_name":"Condensed matter physics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/jm980068d","doi":"https://doi.org/10.1021/jm980068d","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm980068d","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W1549265655","https://openalex.org/W1562245105","https://openalex.org/W1805835817","https://openalex.org/W1864051101","https://openalex.org/W1969319935","https://openalex.org/W1975102679","https://openalex.org/W1976683819","https://openalex.org/W1980204501","https://openalex.org/W1989792394","https://openalex.org/W1995584639","https://openalex.org/W2017254234","https://openalex.org/W2017792639","https://openalex.org/W2026066831","https://openalex.org/W2034258157","https://openalex.org/W2036173317","https://openalex.org/W2036940001","https://openalex.org/W2038073686","https://openalex.org/W2040035983","https://openalex.org/W2045509933","https://openalex.org/W2046639437","https://openalex.org/W2055780736","https://openalex.org/W2063676544","https://openalex.org/W2064791879","https://openalex.org/W2068974401","https://openalex.org/W2069607377","https://openalex.org/W2070932360","https://openalex.org/W2078146467","https://openalex.org/W2081231862","https://openalex.org/W2081309188","https://openalex.org/W2081891116","https://openalex.org/W2082493192","https://openalex.org/W2091379422","https://openalex.org/W2092053095","https://openalex.org/W2094005187","https://openalex.org/W2117942949","https://openalex.org/W2121465721","https://openalex.org/W2145365999","https://openalex.org/W2162416438","https://openalex.org/W2163932237","https://openalex.org/W2167029347","https://openalex.org/W2950410137","https://openalex.org/W2951220809","https://openalex.org/W4205413946","https://openalex.org/W4211140747","https://openalex.org/W4231597303","https://openalex.org/W4245453941"],"related_works":["https://openalex.org/W2026990096","https://openalex.org/W2073942754","https://openalex.org/W2090419315","https://openalex.org/W2170180874","https://openalex.org/W1966272651","https://openalex.org/W1970988101","https://openalex.org/W2001705121","https://openalex.org/W2086743450","https://openalex.org/W2089420544","https://openalex.org/W2120348672"],"abstract_inverted_index":{"The":[0],"structure-based":[1],"design,":[2],"chemical":[3],"synthesis,":[4],"and":[5,26],"biological":[6],"evaluation":[7,90],"of":[8,91,105],"peptide-derived":[9,107],"human":[10],"rhinovirus":[11],"(HRV)":[12],"3C":[13],"protease":[14],"(3CP)":[15],"inhibitors":[16,56],"are":[17,27,57,85],"described.":[18],"These":[19,55],"compounds":[20,93],"incorporate":[21],"various":[22],"Michael":[23,82],"acceptor":[24,83],"moieties":[25],"shown":[28,59],"to":[29,32,47,60],"irreversibly":[30],"bind":[31],"HRV":[33,95],"serotype":[34],"14":[35],"3CP":[36,112],"with":[37,70,88,110],"inhibition":[38],"activities":[39],"(":[40],"k":[41],"obs":[42],"/[I])":[43],"ranging":[44],"from":[45],"100":[46],"600":[48],"000":[49],"M":[50],"-1":[51,53],"s":[52],".":[54],"also":[58,114],"exhibit":[61],"antiviral":[62],"activity":[63],"when":[64],"tested":[65],"against":[66,94],"HRV-14-infected":[67],"H1-HeLa":[68],"cells":[69],"EC":[71],"50":[72],"'s":[73],"approaching":[74],"0.50":[75],"\u03bcM.":[76],"Extensive":[77],"structure\u2212activity":[78],"relationships":[79],"developed":[80],"by":[81],"alteration":[84],"reported":[86],"along":[87],"the":[89],"several":[92],"serotypes":[96],"other":[97],"than":[98],"14.":[99],"A":[100],"2.0":[101],"\u00c5":[102],"crystal":[103],"structure":[104],"a":[106],"inhibitor":[108],"complexed":[109],"HRV-2":[111],"is":[113],"detailed.":[115]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2022-05-12T00:00:00"}
